Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 1;110(1):32-44.
doi: 10.1097/JS9.0000000000000796.

Reappraisal of optimal reconstruction after distal gastrectomy - a study based on the KLASS-07 database

Affiliations
Review

Reappraisal of optimal reconstruction after distal gastrectomy - a study based on the KLASS-07 database

Shin-Hoo Park et al. Int J Surg. .

Abstract

Backgrounds: This study aimed to compare the incidence of bile reflux, quality of life (QoL), and nutritional status among Billroth II (BII), Billroth II with Braun anastomosis (BII-B), and Roux-en-Y (RY) reconstruction after laparoscopic distal gastrectomy (LDG).

Materials and methods: We reviewed the prospective data of 397 patients from a multicentre database who underwent LDG for gastric cancer between 2018 and 2020 at 20 tertiary teaching hospitals in Korea. Postoperative endoscopic findings, QoL surveys using the European Organization for Research and Treatment of Cancer questionnaire (C30 and STO22), and nutritional and surgical outcomes were compared among groups.

Results: In endoscopic findings, bile reflux was the lowest in the RY group ( n =67), followed by the BII-B ( n =183) and BII groups ( n =147) at 1 year (3.0 vs. 67.8 vs. 84.4%, all P <0.05). The anti-reflux capability of BII-B was statistically better than that of BII, but not as perfect as that of RY. From the perspective of QoL, BII-B was not inferior to RY, but better than BII reconstruction in causing fewer STO22 reflux symptoms at 6 and 12 months. However, only RY caused fewer C30 nausea symptoms than BII at 6 and 12 months, but not BII-B. Nutritional status and morbidities were similar among the three groups, and the operative time did not differ between the BII-B and RY groups.

Conclusions: BII-B cannot substitute for RY in preventing bile reflux, shortening the operative time, or reducing morbidities. Regarding short-term QoL, BII-B was sufficient to reduce STO22 reflux symptoms but failed to reduce C30 nausea symptoms postoperatively.

PubMed Disclaimer

Conflict of interest statement

All authors have no conflicts of interest.

Figures

None
Graphical abstract
Figure 1
Figure 1
The amount of residual food and degree of gastritis at postoperative 6 and 12 months in the Billroth II group (n=147), Billroth II with Braun group (n=183), and Roux-en-Y reconstruction group (n=67). (A) The amount of residual food at postoperative 6 months. (B) The amount of residual food at postoperative 12 months. (C) The degree of gastritis at postoperative 6 months. (D) The degree of gastritis at postoperative 12 months. (E) The amount of bile reflux at postoperative 6 months. (F) The amount of bile reflux at postoperative 12 months.
Figure 2
Figure 2
Quality of life (QoL) measurements of the Billroth II (BII) group (n=147), Billroth II with Braun anastomosis (BII-B) group (n=183), and Roux-en-Y reconstruction (RY) group (n=67) using the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) questionnaire. (A) C30 nausea. (B) STO22 reflux.
Figure 3
Figure 3
The nutritional status of hemoglobin, total protein, albumin, and body mass index of the Billroth II (BII) group (n=147), Billroth II with Braun anastomosis (BII-B) group (n=183), and Roux-en-Y reconstruction (RY) group (n=67). (A) The serum level of hemoglobin (mg/l). (B) The serum level of protein (mg/dl). (C) The serum level of albumin (mg/dl). (D) The body mass index (kg/m2).

References

    1. Kim W, Kim HH, Han SU, et al. Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg 2016;263:28–35. - PubMed
    1. Kim HH, Han SU, Kim MC, et al. Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: the KLASS-01 randomized clinical trial. JAMA Oncol 2019;5:506–513. - PMC - PubMed
    1. Kim YW, Baik YH, Yun YH, et al. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 2008;248:721–727. - PubMed
    1. Houghton PW, Mortensen NJ, Thomas WE, et al. Intragastric bile acids and histological changes in gastric mucosa. Br J Surg 1986;73:354–356. - PubMed
    1. Ohira M, Toyokawa T, Sakurai K, et al. Current status in remnant gastric cancer after distal gastrectomy. World J Gastroenterol 2016;22:2424–2433. - PMC - PubMed

MeSH terms